Executive Summary
This one-day snapshot of 28 significant contract modifications (> $10M) totaling $12.8B reveals overwhelming bullish signals (22/28) driven by multi-decade NASA space contracts worth >$7B to primes like Northrop Grumman ($4.4B), Boeing ($1.2B), and Lockheed Martin (2x, $295M combined). Health/IT sectors dominate with stable revenue from HHS/VA/DOL/GSA awards, including long-term extensions to 2030+ for EHRM, student aid, and cybersecurity. Investors should prioritize space/defense equities for option upside (~$4B unexercised) while monitoring fixed-price execution risks and subaward dependencies exceeding 90% in some cases.
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from January 15, 2026.
Investment Signals(3)
- NASA space primes secure $7B+ long-term revenue(HIGH)▲
Northrop ($4.4B to 2026), Boeing ($1.2B to 2027), L3Harris ($1B to 2039), Lockheed (2x, $295M to 2048/2026) dominate with cost-plus awards for propulsion, spacecraft, R&D.
- Health/IT services firms lock in $4B+ through 2029(HIGH)▲
Accenture (2x, $1.6B), Booz Allen ($860M), Novitas ($446M), CACI ($960M) win extensions in student aid, EHRM, Medicare claims processing amid steady federal modernization.
- Small/mid-cap contractors punch above weight in set-asides(MEDIUM)▲
Firms like Defense Unicorns ($53M), Dawes ($47M), Serrato ($43M) secure $300M+ via SDVOSB/HUBZone/8(a) for IT/construction, signaling scalability.
Risk Flags(3)
- Execution[HIGH RISK]▼
Long durations (avg >5yrs, up to 2048) expose to funding shifts/delays; 10+ contracts <20% outlayed despite $3B+ obligated.
- Execution[MEDIUM RISK]▼
Fixed-price structures (12 contracts, $2B+) bear full overrun risk; subawards >90% obligation in 4 cases (e.g., Booz Allen 97%).
- Market[MEDIUM RISK]▼
Negative outlay (-$1.2M) in CACI's $951M intel analysis signals billing disputes/adjustments.
Opportunities(3)
- ◆
$4B+ unexercised options across top contracts (e.g., Lockheed GEOXO $2B potential, CACI $1.5B ceiling).
- ◆
Extensions to 2028-2048 in 15 contracts signal recurring federal priorities in space/health IT.
- ◆
Small biz set-asides (9 contracts, $400M+) offer entry to undervalued govcon plays with follow-on potential.
Sector Themes(3)
- ◆
NASA mods concentrate $7B+ on primes for SLS, GEOXO, DAVINCI through 2048, with cost-plus stability.
- ◆
HHS/VA awards >$2.5B for EHRM, Medicare ops, claims to 2029, favoring IT integrators.
- ◆
12 small/disadvantaged wins ($700M+) via HUBZone/SDVOSB in IT/construction/job training.
Watch List(4)
- 👁
{"entity"=>"Lockheed Martin", "reason"=>"2 NASA awards ($295M obligated, $2.3B options) span 2026-2048 GEOXO/DAVINCI.", "trigger"=>"Option exercise announcements >$500M"}
- 👁
{"entity"=>"Accenture Federal", "reason"=>"2x wins ($1.6B) in Ed/DOI student aid/minerals IT to 2031.", "trigger"=>"Renewal bids post-2025/2026 ends"}
- 👁
{"entity"=>"CACI", "reason"=>"$961M GSA intel task with negative outlay and $1.5B ceiling.", "trigger"=>"Outlay reversal or dispute resolution in 10-Q"}
- 👁
{"entity"=>"NASA Marshall/Goddard Centers", "reason"=>"8 contracts >$7B signal program continuity risks/opportunities.", "trigger"=>"SLS/GEOXO flight test updates"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 28 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC